Innovations in Transcatheter Valve Therapies
Your browser must have Javascript enabled in order for our dynamic player to be embedded. Please turn on Javascript in your browser preferences and then refresh this page.
Discuss the latest clinical trials available for treating valve disease with panelist from NewYork-Presbyterian Hospital/Columbia University Medical Center. The panel will discuss the EVEREST II trial; a prospective, randomized, multi-center phase II IDE clinical study to evaluate its percutaneous mitral valve repair system in the treatment of patients with moderate to severe or severe mitral regurgitation.
The panel will also discuss the initial feasibility study called REVIVAL, (Percutaneous Endovascular Implantation of Valves Trial) which involves the minimally invasive implantation of a heart valve in patients who are at high risk for open-heart surgery.
The live panel discussion will include renowned investigators from both trials. The webcast will be presented Tuesday, April 17, 2007 at 8 PM EDT from NewYork-Presbyterian Hospital/Columbia University Medical Center.
Panelists Dr. Jeffrey W. Moses, Dr. Martin B. Leon and Dr. William A. Gray will present the procedures and accept questions from the viewers during the live webcast.
Participants
Featuring:
Jeffrey Moses, MD
Martin Leon, MD
William Gray, MD, FACC, FSCAI
Associate Professor of Clinical Medicine, Director, Endovascular Services, Columbia University Medical CenterNew York Presbyterian Hospital
Neil Goyal, MD, MPH